Related Experiment Video
Updated: Mar 29, 2026

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
Published on: February 14, 2022
Pulmonary Protothecosis in a Pediatric Liver Transplant Patient
Ronald M R Tan1, Marion M Aw1, Seng Hock Quak1
1Department of Paediatrics, Khoo Teck Puat - National University Children's Medical Institute, National University Hospital, Singapore.
Abstract:
Immunocompromised patients are susceptible to infections from common and unusual microorganisms. Protothecosis is seldom suspected on clinical grounds, yet it is readily diagnosed once detected in the laboratory. We report the first pediatric liver transplant recipient with pulmonary protothecosis, detected during an episode of Pneumocystis jirovecii pneumonia, and we conducted a review of the available literature.
Insights
Protothecosis, an infection caused by algae, is rare in immunocompromised individuals. This study details the first pediatric liver transplant case of pulmonary protothecosis, identified alongside Pneumocystis jirovecii pneumonia.
Area of Science:
- Infectious Diseases
- Transplant Medicine
- Microbiology
Background:
- Immunocompromised patients face risks from diverse pathogens.
- Protothecosis is an uncommon infection caused by algae, often overlooked clinically.
- Early laboratory diagnosis is crucial for managing protothecosis.
Purpose of the Study:
- To report the first pediatric liver transplant recipient diagnosed with pulmonary protothecosis.
- To highlight the co-occurrence of protothecosis with Pneumocystis jirovecii pneumonia in this patient.
- To review existing literature on protothecosis in immunocompromised populations.
Main Methods:
- Case report of a pediatric liver transplant recipient.
- Diagnostic identification of pulmonary protothecosis.
- Literature review of protothecosis cases.
Main Results:
- The study identified the first pediatric liver transplant case of pulmonary protothecosis.
- Protothecosis was detected during treatment for Pneumocystis jirovecii pneumonia.
- Literature review provided context on protothecosis in immunocompromised patients.
Conclusions:
- Pulmonary protothecosis can occur in pediatric liver transplant recipients.
- Co-infection with Pneumocystis jirovecii pneumonia is possible.
- Increased awareness and laboratory vigilance are necessary for diagnosing protothecosis.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Kidney Transplant I: Introduction
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

